Nuveen Asset Management, LLC Athersys, Inc Transaction History

Nuveen Asset Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.18 - $0.86 $100,235 - $478,901	-556,862 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.6 - $1.06 $2,242 - $3,961	3,737 Added 0.68%	556,862 $395,000
Q4 2021 Feb 14, 2022	SELL	$0.85 - $1.4 $50,861 - $83,771	-59,837 Reduced 9.76%	553,125 $542,000
Q3 2021 Nov 12, 2021	SELL	$1.33 - $1.77 $24,213 - $32,224	-18,206 Reduced 2.88%	612,962 $901,000
Q2 2021 Aug 16, 2021	SELL	$1.41 - $1.94 $42 - $58	-30 Reduced -0.0%	631,168 $909,000
Q1 2021 May 17, 2021	SELL	$1.61 - $2.77 $29,292 - $50,397	-18,194 Reduced 2.8%	631,198 $1.14 Million
Q4 2020 Feb 16, 2021	BUY	$1.55 - $2.24 $13,773 - $19,904	8,886 Added 1.39%	649,392 $1.14 Million
Q3 2020 Nov 16, 2020	SELL	$1.91 - $3.08 $302,521 - $487,835	-158,388 Reduced 19.83%	640,506 $1.25 Million
Q2 2020 Aug 14, 2020	BUY	$1.97 - $3.98 $272,691 - $550,919	138,422 Added 20.96%	798,894 $2.21 Million
Q1 2020 May 14, 2020	BUY	$1.17 - $3.0 $45,594 - $116,910	38,970 Added 6.27%	660,472 $1.98 Million
Q3 2019 Nov 14, 2019	BUY	$1.21 - $1.65 $24,955 - $34,029	20,624 Added 3.43%	621,502 $827,000
Q2 2019 Aug 15, 2019	BUY	$1.39 - $2.03 $835,220 - $1.22 Million	600,878 New	600,878 $1.01 Million

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.